| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.1M | — |
| R&D Expense | $80.8M | +18.8% |
| SG&A Expense | $52.0M | +106.9% |
| Operating Income | -$101.7M | -9.2% |
| Interest Expense | $18.9M | +27.1% |
| Income Tax | $0 | — |
| Net Income | -$105.4M | +0.6% |
| EPS (Basic) | -$0.99 | +18.2% |
| EPS (Diluted) | -$0.99 | +18.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $206.5M | +917.9% |
| Current Assets | $403.8M | +192.5% |
| Total Assets | $434.7M | +206.4% |
| Current Liabilities | $36.8M | +138.6% |
| Total Liabilities | $142.4M | +34.8% |
| Stockholders' Equity | $292.3M | +708.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.5M | +13.7% |
| Capital Expenditures | $445K | +200.7% |
| Investing Cash Flow | -$86.6M | -88.3% |
| Financing Cash Flow | $345.8M | +1308.4% |
| Free Cash Flow | -$73.0M | +13.4% |